NYSE CRTR Economy Event Watch the replay →

Advertisement
Advertisement

ALPS Medical Breakthroughs ETF

This ETF provides exposure to Mid and Small-Cap US Equities

SBIO performance and flow charts

Last update 6/12/2026 at 1:30 PM
Live
Closed
Last price
$52.76
+$0.67 (+1.29%) Yesterday

Performance

-8.0-6.0-4.0-2.00.0%May 12May 19May 27Jun 3Jun 10

Flows

0 M0.5 M1 M1.5 M2 M2.5 M
1 day price range
$52.19
$53.60
52 week price range
$29.98
$57.54
1W perf
+4.63%
YTD perf
+3.34%
YTD flows
+$24M
AuM
$155M
E/R
0.5%
TTM yield
-
Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

Historic performance and flows

Data as of June 12, 2026
1M3MYTD1Y3Y5Y
Perf.-4.14%+5.20%+3.34%+68.87%+65.55%+9.66%
Flows+$152K+$15M+$24M+$22M+$69K-$48M
Data as of June 12, 2026
Advertisement

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Characteristics

The ALPS Medical Breakthroughs ETF is built to track the S-Network Medical Breakthroughs Index NTR - USD. This ETF provides physical exposure - by owning its shares you earn the return of the securities composing the index (as the ETF holds them directly). This share class generates a stream of income by distributing dividends.

Management strategyPassive
StrategyLong Only
ProviderALPS
N° of holdings0
Replication methodDirect (Physical)
Asset classEquity
Dividend policyDistributing
Trailing 12m distribution yield
Join for free
Inception dateDecember 30, 2014
ESGNo
TrackinsightTrackinsight

More data and info about SBIO on Trackinsight

Exposure

Data as of January 1, 1970
The SBIO ETF provides physical exposure, so by buying it you actually own parts of all the underlying holdings. We're working to retrieve all detailed holding information.
Advertisement

Trading data

Last sale
6/12/2026 at 1:30 PM
$52.76
Previous close
$52.09
Consolidated volume
06/11/2026
Join for free
Average volume
30 days
Join for free
Average discount or premium
30 days
Join for free
Average Bid/Ask spread
30 days
Join for free

Volatility and drawdown

3M1Y3Y5Y
Volatility+34.60%+29.49%+30.27%+33.65%
Max drawdown
-12.63%-12.63%-42.12%-53.11%
Max drawdown duration
54d54d331d1611d
Time to recover
N/AN/A184d760d

Replication quality

Data as of May 29, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free
Tracking error
Join for free
Tracking difference
Join for free
1 year cumulative return difference
Best
Join for free
Worst
Join for free
daily return difference
Average
Join for free
Worst
Join for free
Advertisement
Frequently asked questions about SBIO

What type of ETF is SBIO?

SBIO is a Passive ETF that provides exposure to Equity assets. It is managed by ALPS.

What index does SBIO track?

SBIO tracks the S-Network Medical Breakthroughs Index NTR - USD, aiming to replicate its performance through full replication.

What does SBIO invest in?

This ETF provides exposure to Mid and Small-Cap US Equities. It is part of the segment: Tomorrow's Treatments.

What is the expense ratio of SBIO?

The total expense ratio (TER) of SBIO is 0.5%, representing the annual fee charged by the fund manager.

When was SBIO launched?

SBIO was launched on December 30, 2014, marking its entry into the ETF market.

Who is the issuer of SBIO?

SBIO is issued by ALPS.

What is the AUM of SBIO?

As of June 12, 2026, SBIO manages $154.56 M, reflecting the total assets held in the fund.

How has SBIO performed recently?

As of June 12, 2026, SBIO delivered a return of -4.14% over the past month (1M performance), 5.2% over the past three months (3M), and 3.34% year-to-date (YTD).

What are the recent fund flows for SBIO?

As of June 12, 2026, SBIO has seen net flows of +$152K in the past month (1M flow) and +$24M year-to-date (YTD).

The ETF Institute® is now affiliated with ETF Central

The CETF certification is the only FINRA listed professional designation focused on ETFs.

ETF Institute
Advertisement
Advertisement
ETF U
Become a better investor with NYSE: The Home of ETFs
Visit the ETF U homepage
ETF Guides
Advertisement

Recent educational content

The ETF Show - New Autism-Impact ETF Launched

Asset TV

The ETF Show - New Autism-Impact ETF Launched

Defiance ETFs has launched the first ETF, $ASD, focused on the autism ecosystem, investing in companies that provide services, products, and research related to autism and neurodivergence.

Asset TV
By Asset TV · June 4, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs June 1, 2026

The ETF Industry saw 22 New Launches, 1 Ticker Change and 1 closure last week.

Tidal
By Tidal · June 1, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs May 20, 2026

The ETF Industry saw 44 New Launches, 3 Mutual Fund Conversions and 9 closures last week.

Tidal
By Tidal · May 19, 2026
The ETF Show - Politics Becomes Investable Trade through ETFs

Asset TV

The ETF Show - Politics Becomes Investable Trade through ETFs

Dan Weiskopf, Senior Portfolio Manager at Tidal Financial Group spoke with the ETF Show about Subversive ETFs that help investors trade like politicians.

Asset TV
By Asset TV · May 18, 2026

Browse all educational columns

Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up